After a 25% crash, is this ASX 200 stock in deep value territory?

This $13 billion company has been kicked the curb. It might be worth inspecting.

Not all stocks featured in the S&P/ASX 200 Index (ASX: XJO) have performed as swimmingly as the benchmark. Some of the index's biggest constituents meet the 'crash' criteria — falling 20% or more — despite the ASX 200 being up 10.3% over the past 12 months.

Sometimes, this visible divergence between the broader market and individual companies is where 'deep value' can be discovered. If the pessimism is misplaced, these shares can suddenly spring back once investors realise it.

I think a 90-year-old cornerstone of the healthcare industry has fallen into this camp.

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.

Image source: Getty Images

No more pandemic hangover for this ASX 200 stock

The COVID-19 pandemic injected a huge boost to Sonic Healthcare Ltd (ASX: SHL) between 2020 and 2022. As a pathology and laboratory heavyweight, Sonic's revenues surged from all the COVID-19 testing needed during this time.

In FY2022, approximately 26% of Sonic Healthcare's record-breaking $9.3 billion revenue came from COVID testing. However, demand for such services has rapidly dwindled since, falling to only $39 million in the first half of FY2024.

Where's the good news in losing roughly $2.4 billion of revenue in two years?

Well, the impact from here is capped at $39 million. Because of this, we can begin focusing back on the company's base business: traditional pathology, laboratory, and radiology services. Without the anchor of falling COVID revenues, we may start seeing a recovery in earnings.

Survival of the biggest

This ASX 200 stock currently trades at a price-to-earnings (P/E) ratio of 25 times. For reference, the global healthcare industry average is around 23 times earnings. Based on this, Sonic Healthcare appears to be nowhere near 'deep value' relative to its peers.

However, it's worth thinking about the industry dynamics currently at play.

Rising costs and flat medical rebates are putting pressure on the entire diagnostics industry. I believe this will create an environment where only the largest operators can succeed. Personally, I think this is why we're seeing Sonic Healthcare gobble up smaller competitors abroad.

There is some intrinsic value in being one of the biggest players.

Given the industry headwinds, I don't know if this ASX 200 stock can be labelled 'deep value'. However, the current $26.68 price tag is attractive when I take a long-term perspective on the company.

Motley Fool contributor Mitchell Lawler has positions in Sonic Healthcare. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

A woman relaxes on a yellow couch with a book and cuppa, and looks pensively away as she contemplates the joy of earning passive income.
Opinions

3 reasons why I think this leading ASX 200 share is a buy

This underrated business could be a top buy today…

Read more »

A woman sprints with a trail of fire blazing from her body.
Opinions

I hunted the ASX for shares with the potential to double. This one stood out

Do you have this ASX share in your investment portfolio?

Read more »

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Opinions

I wanted growth, not hype. Only 3 ASX shares passed my checks

One of these ASX shares is tipped to climb up to 38%.

Read more »

Man with his hands out as if pondering his options.
Opinions

I've always loved Wesfarmers shares. But after a trip to Kmart, I'm not so sure

A weekend trip took some gloss off this stock.

Read more »

Piles of increasing coins alongside an hourglass.
Opinions

Why I'm planning to buy more Soul Patts shares in 2027

I think Soul Patts is a great long-term buy.

Read more »

a close up of a woman's face looks skywards as she is showered in a sea of graphic symbols of gold and silver coins bearing the bitcoin logo.
Cryptocurrencies

Are you a 'greater fool' for owning Bitcoin?

Is Bitcoin truly an investment?

Read more »

A woman in a red dress holding up a red graph.
Opinions

I went looking for shares which could double by 2030. These 3 made my shortlist

All of these shares are in recovery mode.

Read more »

A little girl is surprised at a science experiment.
Opinions

2 ASX shares with the potential to double in a year, and the risk that keeps me cautious

One of these ASX shares could climb up to 123% higher.

Read more »